subject area of
- Acylcarnitines are anticoagulants that inhibit factor Xa and are reduced in venous thrombosis, based on metabolomics data Academic Article
- Binding sites for blood coagulation factor Xa and protein S involving residues 493-506 in factor Va Academic Article
- Design, synthesis, and biological evaluation of peptidomimetic inhibitors of factor XIa as novel anticoagulants Academic Article
- Different DOACs Control Inflammation in Cardiac Ischemia-Reperfusion Differently Academic Article
- Effector cell protease receptor-1 is a vascular receptor for coagulation factor xa Academic Article
- Identification of divalent metal ion-dependent inhibition of activated protein-C by alpha-2-macroglobulin and alpha-2-antiplasmin in blood and comparisons to inhibition of factor-Xa, thrombin, and plasmin Academic Article
- Influence of blockade at specific levels of the coagulation cascade on restenosis in a rabbit atherosclerotic femoral-artery injury model Academic Article
- Interactions and inhibition of blood-coagulation factor-Va involving residues 311-325 of activated protein-C Academic Article
- Ligand-induced protease receptor translocation into caveolae: A mechanism for regulating cell surface proteolysis of the tissue factor-dependent coagulation pathway Academic Article
- Nmr solution structure of the recombinant tick anticoagulant protein (rtap), a factor xa inhibitor from the tick ornithodoros-moubata Academic Article
- Protein-S binds to and inhibits factor-Xa Academic Article
- Selective inhibition of factor xa during thrombolytic therapy markedly improves coronary artery patency in a canine model of coronary thrombosis Academic Article
- Selective inhibition of factor xa is more efficient than factor viia-tissue factor complex blockade at facilitating coronary thrombolysis in the canine model Academic Article